Drug intelligence / Profile preview

d-chiro-inositol

Development stage
Preclinical
Lead developer
DMC Biotechnologies
Modality
Small Molecules
Administration
Oral
01

Overview

D-chiro-inositol is a naturally occurring stereoisomer of inositol, a cyclitol found in animal and plant cells. It is derived from myo-inositol through an insulin-dependent epimerization process. D-chiro-inositol acts primarily as an insulin sensitizer and plays a role in various signal transduction pathways, including those involving insulin and gonadotropins. Its mechanisms include enhancing insulin sensitivity, inhibiting aromatase transcription, and modulating the transdifferentiation between white adipose tissue and brown adipose tissue. These actions make it relevant for metabolic disorders such as polycystic ovary syndrome (PCOS), obesity, dysmetabolism (including type 2 diabetes mellitus), hypoestrogenic/hyperandrogenic disorders, and potentially bone health[1][5][6][8]. D-chiro-inositol is most commonly used as a dietary supplement rather than a pharmaceutical drug.

Brand names
Caronositol
Other names
DCIinositol (D-chiro form)
02

Targets

CYP19A1 (Aromatase)

Beyond the preview

Go deeper on d-chiro-inositol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on d-chiro-inositol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call